{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:39:57Z","timestamp":1790397597075,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":952,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL101972"],"award-info":[{"award-number":["HL101972"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL106919"],"award-info":[{"award-number":["HL106919"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL128016"],"award-info":[{"award-number":["HL128016"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL140025"],"award-info":[{"award-number":["HL140025"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI088937"],"award-info":[{"award-number":["AI088937"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS077600"],"award-info":[{"award-number":["NS077600"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM116184"],"award-info":[{"award-number":["GM116184"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1002\/rth2.12349","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T15:08:20Z","timestamp":1587222500000},"page":"500-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["The contact activation system as a potential therapeutic target in patients with COVID\u201019"],"prefix":"10.1016","volume":"4","author":[{"given":"Joseph J.","family":"Shatzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma P.","family":"DeLoughery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina U.","family":"Lorentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik I.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8873-0387","authenticated-orcid":false,"given":"Joseph E.","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica T.","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gailani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen J.T.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12349_bb0010","doi-asserted-by":"crossref","unstructured":"Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H.Effective treatment of severe COVID\u201019 patients with tocilizumab. ChinaXiv:20200300026 2020; in press.","DOI":"10.1073\/pnas.2005615117"},{"key":"10.1002\/rth2.12349_bb0015","unstructured":"Genentech: Press Releases | Monday, March 23, 2020."},{"issue":"4","key":"10.1002\/rth2.12349_bb0020","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1002\/rth2.12349_bb0025","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1002\/rth2.12349_bb0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary pathology of early\u2010phase 2019 novel coronavirus (COVID\u201019) pneumonia in two patients with lung cancer","volume":"15","author":"Tian","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1002\/rth2.12349_bb0035","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0000000000002694","article-title":"Is there a role for tissue plasminogen activator (tPA) as a novel treatment for refractory COVID\u201019 associated acute respiratory distress syndrome (ARDS)?","author":"Moore","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1002\/rth2.12349_bb0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rth2.12217","article-title":"The contact pathway and sepsis","volume":"3","author":"Raghunathan","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1002\/rth2.12349_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1128\/IAI.05568-11","article-title":"Factor XI\u2010deficient mice display reduced inflammation, coagulopathy, and bacterial growth during listeriosis","volume":"80","author":"Luo","year":"2012","journal-title":"Infect Immun"},{"key":"10.1002\/rth2.12349_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/ATVBAHA.107.156273","article-title":"Thrombin mutant W215A\/E217A acts as a platelet GPIb antagonist","volume":"28","author":"Berny","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/rth2.12349_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152968","article-title":"Deficiency alters the cytokine response and activation of contact proteases during polymicrobial sepsis in mice","volume":"11","author":"Bane","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1002\/rth2.12349_bb0060","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood-2011-10-386185","article-title":"Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis","volume":"119","author":"Tucker","year":"2012","journal-title":"Blood"},{"issue":"22","key":"10.1002\/rth2.12349_bb0065","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","article-title":"In vivo roles of factor XII","volume":"120","author":"Renn\u00e9","year":"2012","journal-title":"Blood"},{"key":"10.1002\/rth2.12349_bb0070","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI77139","article-title":"Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III","volume":"125","author":"Bj\u00f6rkqvist","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1002\/rth2.12349_bb0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-0039-1692439","article-title":"The safety and efficacy of novel agents targeting factors XI and XII in early phase human trials","volume":"45","author":"DeLoughery","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1002\/rth2.12349_bb0080","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.jacc.2019.08.1028","article-title":"Anticoagulation with an inhibitor of factors XIa and XIIa during cardiopulmonary bypass","volume":"74","author":"Pireaux","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/rth2.12349_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1172\/JCI116201","article-title":"The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti\u2010factor XII antibody to block contact activation in baboons","volume":"91","author":"Pixley","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1002\/rth2.12349_bb0090","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.V87.6.2337.bloodjournal8762337","article-title":"Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin\u20106 and neutrophil elastase","volume":"87","author":"Jansen","year":"1996","journal-title":"Blood"},{"key":"10.1002\/rth2.12349_bb0095","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/bloodadvances.2018029983","article-title":"Inhibition of contact\u2010mediated activation of factor XI protects baboons against S aureus\u2010induced organ damage and death","volume":"3","author":"Silasi","year":"2019","journal-title":"Blood Adv"},{"issue":"Suppl 1","key":"10.1002\/rth2.12349_bb0100","first-page":"127","article-title":"Blocking activated factor XII with a monoclonal antibody prevents organ failure and saves baboons challenged with heat\u2010inactivated S aureus","volume":"3","author":"Lupu","year":"2019","journal-title":"Res Pr Thromb Haemost"},{"key":"10.1002\/rth2.12349_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1405760","article-title":"Factor XI antisense oligonucleotide for prevention of venous thrombosis","volume":"372","author":"B\u00fcller","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12349_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jama.2019.20687","article-title":"Effect of osocimab in preventing venous thromboembolism among patients undergoing knee arthroplasty: the FOXTROT randomized clinical trial","volume":"323","author":"Weitz","year":"2020","journal-title":"JAMA"},{"key":"10.1002\/rth2.12349_bb0115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/ATVBAHA.118.312328","article-title":"Contact activation inhibitor and factor XI antibody, AB023, produces safe, dose\u2010dependent anticoagulation in a phase 1 first\u2010in\u2010human trial","volume":"39","author":"Lorentz","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/rth2.12349_bb0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2052.2004.01202.x","article-title":"Identification of a mutation associated with factor XI deficiency in Holstein cattle","volume":"35","author":"Marron","year":"2004","journal-title":"Anim Genet"},{"key":"10.1002\/rth2.12349_bb0125","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/hae.13463","article-title":"Factor XI deficiency is not associated with an increased risk of pneumonia and pneumonia\u2010related mortality","volume":"24","author":"Salomon","year":"2018","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12349_bb0130","doi-asserted-by":"crossref","first-page":"L163","DOI":"10.1152\/ajplung.00320.2016","article-title":"Factor XI deficiency enhances the pulmonary allergic response to house dust mite in mice independent of factor XII","volume":"312","author":"Stroo","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1002\/rth2.12349_bb0135","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1160\/TH16-12-0920","article-title":"Coagulation factor XI improves host defence during murine pneumonia\u2010derived sepsis independent of factor XII activation","volume":"117","author":"Stroo","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12349_bb0140","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1182\/blood-2019-02-900480","article-title":"MAA868 locks factor XIa in a zymogen\u2010like state","volume":"133","author":"Weitz","year":"2019","journal-title":"Blood"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12349","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12349","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:21:08Z","timestamp":1762863668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922020179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2475037922020179"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12349","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contact activation system as a potential therapeutic target in patients with COVID\u201019","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}